GAGLIARDINI, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 1.195
NA - Nord America 947
AS - Asia 205
AF - Africa 13
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.373
Nazione #
US - Stati Uniti d'America 939
GB - Regno Unito 282
IT - Italia 238
IE - Irlanda 228
SE - Svezia 109
RU - Federazione Russa 82
CN - Cina 68
DE - Germania 65
FR - Francia 65
VN - Vietnam 57
SG - Singapore 46
UA - Ucraina 35
FI - Finlandia 28
ES - Italia 19
BE - Belgio 18
IN - India 10
AT - Austria 9
BR - Brasile 6
CA - Canada 6
NL - Olanda 6
ID - Indonesia 5
TR - Turchia 5
ZA - Sudafrica 5
AU - Australia 3
JP - Giappone 3
PT - Portogallo 3
ET - Etiopia 2
EU - Europa 2
LT - Lituania 2
PA - Panama 2
PH - Filippine 2
UG - Uganda 2
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 2.373
Città #
Southend 266
Dublin 216
Chandler 113
Santa Clara 109
Fairfield 96
Ashburn 83
Dong Ket 56
Ann Arbor 52
Siena 44
Woodbridge 40
Munich 38
Singapore 37
Princeton 33
Seattle 32
Jacksonville 31
Menlo Park 29
Helsinki 28
Wilmington 28
Houston 27
Beijing 21
Cambridge 21
New York 20
Málaga 19
Brussels 15
Rome 15
Dearborn 13
Milan 13
Shanghai 13
San Mateo 12
Nanjing 10
Boardman 8
Perugia 8
Vienna 7
Washington 7
Frankfurt am Main 6
Fremont 6
Moscow 6
London 5
Spring 5
Deiva Marina 4
Florence 4
Izmir 4
San Diego 4
San Francisco 4
Bologna 3
Cagliari 3
Campobasso 3
Genoa 3
Guangzhou 3
Nanchang 3
Norwalk 3
Oxford 3
Porto 3
Recife 3
Redwood City 3
Scottville 3
Tokyo 3
Addis Ababa 2
Andover 2
Arezzo 2
Bandung 2
Bari 2
Brackenfell 2
Bronte 2
Bussero 2
Casciana Terme 2
Dallas 2
Elixhausen 2
Foggia 2
Giarre 2
Grosseto 2
Hefei 2
Hillsboro 2
Hyderabad 2
Jinan 2
Johannesburg 2
Leuven 2
Luino 2
Macerata 2
Manila 2
Naples 2
Ozieri 2
Palermo 2
Phoenix 2
Pontirolo Nuovo 2
Pozzuoli 2
Rende 2
San Donà Di Piave 2
San Giovanni Valdarno 2
Santa Maria a Monte 2
Semarang 2
Stoney Creek 2
Taizhou 2
Taranto 2
Toronto 2
Treviso 2
Winnipeg 2
Abidjan 1
Aci Castello 1
Albuquerque 1
Totale 1.730
Nome #
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 282
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 251
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 175
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 173
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 158
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 152
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 144
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort 140
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 128
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 125
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 111
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: A multi-cohort study 89
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 83
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry 82
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 72
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 62
Efficacia viro-immunologica dei regimi antiretrovirali duplici e triplici contenenti dolutegravir: risultati di uno studio di coorte 55
Endocardite o non endocardite? Questo è il dilemma. 53
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 52
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 17
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 13
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 8
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 8
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 8
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 7
Sexually transmitted infections in people with multidrug-resistant HIV 7
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment‐experienced HIV‐positive patients: the experience of an Italian centre 7
Totale 2.462
Categoria #
all - tutte 8.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 0 0 0 0 0 0 72 38 31 27 15 19
2020/2021385 17 20 3 21 57 29 33 41 37 36 13 78
2021/2022300 11 31 16 23 17 13 19 18 34 20 30 68
2022/2023421 26 51 65 41 25 76 15 32 33 28 15 14
2023/2024435 12 8 38 28 20 114 125 16 2 15 29 28
2024/2025442 19 31 81 33 148 107 23 0 0 0 0 0
Totale 2.462